Related Experiment Video
Updated: May 13, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Exploiting online discussions to discover unrecognized drug side effects
1University of Delaware, Newark, DE 19716, USA. haow@udel.edu
Methods of Information in Medicine
|March 2, 2013
Summary
Online patient discussions can identify unrecognized drug side effects. This approach aids drug companies and the FDA in early detection, improving patient safety and healthcare quality.
Area of Science:
- Pharmacovigilance
- Computational Linguistics
- Data Mining
Background:
- Adverse drug reactions stem from unintended interactions with off-targets.
- Early notification of potential drug effects is crucial for healthcare quality.
- Online patient forums offer a rich source of real-world drug side effect information.
Purpose of the Study:
- To investigate the feasibility of using online patient discussions to discover previously unrecognized drug side effects.
- To develop and evaluate methods for mining drug side effect knowledge from diverse online sources.
Main Methods:
- Automated construction of a comprehensive drug side effect knowledge base by integrating information from multiple sources.
- Monitoring online discussions to identify potential unrecognized drug side effects using generative and discriminative models.
Main Results:
- Online discussions provide valuable data for discovering unrecognized drug side effects.
- The integrated knowledge base surpasses individual sources in information content.
- Detection methods successfully identified side effects for recalled drugs, often preceding official announcements.
- Generative modeling proved more effective than discriminative approaches.
Conclusions:
- Monitoring online patient discussions is a viable strategy for detecting unrecognized drug side effects.
- The developed system can assist drug companies and regulatory agencies (FDA) in patient feedback and early detection.
- This approach has the potential to accelerate the discovery of adverse drug events and enhance healthcare quality.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...